Method and apparatus for detecting mastitis
6 claims: 1 independent, 5 dependent
- 1A method of testing milk from an animal for the presence of an infection in the animal, the method including the steps of introducing a sample of milk and a reagent including light amplifying compound into a reaction chamber (18), the light amplifying compound reacting with a substance produced by phagocytic leukocytes of the animal in response to infection to emit light, including an initial light burst, and immediately measuring the intensity of any light emitted from the sample, to detect the presence of the initial light burst.
61 paragraphs, as filed
0001The present invention relates to a method of and apparatus for testing a biological fluid
0002It is known to test a biological fluid for the presence of bacteria cells or somatic cells in the fluid. Such a test may be carried on milk produced by dairy cows and other mammals to determine whether the animal is suffering from mastitis. For example, laboratory testing of milk samples taken by milk collection operatives is regularly carried out.
0003Known such tests may involve determining the number of bacteria cells or somatic cells in the sample for a direct indication of the presence of mastitis. The standard test method involves the use of a flow cytometer to count the bacteria in a fluid sample. As the cost of the necessary equipment and the skill level required to maintain the equipment is high, and use of the equipment. requires a controlled environment, this method is generally performed in a dedicated laboratory. Alternatively, bacteria or somatic cell levels may be determined by microscopic examination of a milk sample using dyes to enhance cell visibility. Such a test is, however, very time consuming and must be carried out by a highly trained technician, and is generally suitable only for use in a laboratory environment.
0004Indirect test methods may also be used, for example determining the level of other biological agents such as enzymes, proteins, or other organic compound in a sample. As these methods rely on the use of very precise amounts and concentrations of reagents, they are most suited to use in a laboratory, although carefully designed and packaged kits can be used to carry out such methods in a farm environment, as illustrated in our UK patent application <patcit id="pcit0001" dnum="GB2350421A"><text>GB2350421</text></patcit>.
0005A problem with known laboratory based testing is that there is inevitably a delay between when the sample is taken and when the test results are available. Mastitis can progress rapidly and so the test results may not be accurately indicative of the state of the disease when for example the animal is next milked. Also a laboratory based test on a sample taken by a collection operative (tanker driver), is most likely to include milk produced by a plurality of animals. Thus such tests, whilst being of some use in determining milk quality from a particular farm, are not useful in advising a dairyman for example, as to which of his animals is suffering from mastitis.
0006Thus a dairyman needs to be able to perform tests on individual animals which will give a rapid result, so that the dairyman can be alerted to an animal which is suffering from mastitis. In response, the dairyman may decide to dispose of an individual animal's milk so as not to lower the quality of milk from the herd, and may make a decision either to treat the animal e.g. with antibiotics, or to allow the animal's own immune system to combat the infection.
0007In each case, early diagnosis of mastitis is important to enable the dairyman proactively to maintain the quality of the herd's milk provided for production, to provide for timely, appropriate treatment of individual animals in the herd, and to maintain expected milk quality.
0008Milk tests are known which are intended to be performed by a dairyman, and these include the Califormian Mastitis Tests (CMT) or the Wisconsin Mastitis Test (WMT). However to perform such tests, the tester needs to make subjective judgements which a dairyman may not be suffciently skilled to make. Also such tests exhibit a lack of sensitivity for detecting subclinical mastitis, and lack accuracy at somatic cell count levels required by current rules and regulations.
0009Another test method which may be used in the field is the conductivity test, in which a DC voltage is applied across a milk sample, and the resulting current measured. The current gives some indication of the quality of the sample, but the current is also strongly affected by other variables such as temperature and changes in diet of the cow, and therefore the results are not regarded as particularly accurate or reliable.
0010As mentioned above, portable, carefully designed and packaged test kits for use by -a dairyman in the field, which produce accurate and reliable test results are known, but these too require the dairyman to take the time to carry out the test and to note the results.
0011Economic pressures on farmers are ever increasing, and, particularly on large farms, milking is becoming ever more automated and comparable to an industrial production line. There is pressure to reduce the time required to milk each cow, and to reduce the amount of human intervention required Thus, there is a need for a fully automated milk testing method which can be incorporated into the milking "production line" and used to test the milk from each cow every day, or even every milking, without requiting a dairyman to spend time testing each animal.
0012The conductivity test method has been incorporated into automatic. milking systems, but as discussed above, the results are inaccurate and unreliable.
0013<patcit id="pcit0002" dnum="US6297045B"><text>US patent number 6297045</text></patcit> discloses an apparatus and method for testing milk samples in which mastitis is detected by measuring the level of intensity of light chemically emitted by phagocytic leukocytes when they phagocytose bacteria in the milk sample. When an infection is detected by the body, the body uses phagocytic leukocytes such as neutrophils as the first line of attack against the infection. Thus, the number of neutrophils in a sample gives an indication as to whether infection is present.
0014Neutrophils engulf and digest bacterial cells in a process known as phagocytosis. During this process, active oxygen, or "superoxide" intermediates are produced and play a role in killing the bacteria. The superoxides are highly reactive and will react with light amplifiers such as luminol to produce photons of light in proportion of the amount of superoxide released. In the test method of <patcit id="pcit0003" dnum="US6297045B"><text>US6297045</text></patcit>, a phagocyte stimulator zymosan is added to induce phagocytic reaction in the neutrophils present in the sample, and the sample is incubated, typically for about 20 minutes, to allow time for the neutrophils to respond to the phagocytic stimulator before light measurements are commenced. Thus the test, which requires a stimulator such as zymosan is essentially an in vitro test
0015Thus, by measuring the amount of light emitted, the number of neutrophils in a sample, and hence the degree of infection, can be determined.
0016Because the test requires an incubation time of at least 20 minutes, to allow the phagocyte stimulator to take effect, this test takes too long for it to be usefully incorporated in an automated milking system.
0017<patcit id="pcit0004" dnum="EP0489602A"><text>EP 0489602</text></patcit> discloses a method of analysing particulate matter extracted from a sample of biological fluid such as milk in which the fluid is passed through a filter, which is configured to retain particles, such as leucocytes, platelets or bacteria, present in the fluid sample. The retained particulate matter is then reacted with a luminescent material such as luminol, and the resulting light output measured. <patcit id="pcit0005" dnum="GB2001434A"><text>GB 2001434</text></patcit> discloses the optical analysis of milk using a reagent mixed with the sample and placed in a photometer for analysis.
0018According to the invention we provide a method of testing milk from an animal for the presence of an infection in the animal according to claim 1, the method including the steps of introducing a sample of milk and a reagent including light amplifying. compound into a reaction chamber, the light amplifying compound reacting with a substance produced by phagocytic leukocytes of the animal in response to infection to emit light, and immediately measuring the intensity of any light emitted from the sample.
0019Thus the method of the invention provides a test which does not require the use of any stimulator. Rather, the test is essentially an in vivo test, looking at the results of the phagocytic reaction as soon as possible after mixing the samples and reagent, by measuring the superoxide concentration.
0020Preferably the light amplifying compound reacts with a compound produced when phagocytic leukocytes phagocytose bacteria to emit light.
0021Further preferably, the light amplifying compound reacts with reactive oxygen to emit light.
0022It has been found that neutrophils in a biological fluid sample from an infected animal are phagocytically active when the sample is collected, and the superoxide produced by such neutrophils reacts with the light amplifier to produce an initial light burst. No such light burst is produced from a biological fluid sample from a healthy animal.
0023The burst of light is of relatively short duration, and therefore light measurements must be commenced immediately. Consequently, testing may be completed within around 1 minute, and therefore the invention provides a rapid method of testing for the presence of diseases in animals, such as mastitis, which is suitable for incorporation into an automated milking system.
0024Preferably, the method further includes the step of recording the intensity of light emitted by the sample using a data recording and processing device such as a PC.
0025Preferably the intensity of light emitted from the sample is measured using a photodiode.
0026Preferably the light amplifier is luminol.
0027The reagent preferably further includes a pH buffered iron solution, e.g. to increase the light output of the light amplifier which typically is luminol.
0028The method may further include the steps of connecting a first inlet port of generally a fluid and light tight reaction chamber of variable capacity to a milk line in an automated milking system, connecting a second inlet port of the reaction chamber to a supply of reagent, increasing the capacity of the chamber in order to draw milk and reagent into the chamber.
0029Thus, the method allows testing of milk within an automated system to be carried without human intervention.
0030The method may further include the step of controlling electrically operating valves provided in the inlet ports to regulate the proportion of reagent and sample drawn into the reaction chamber.
0031The capacity of the reaction chamber may be increased by movement of a piston, in which case, the piston may be actuated by means of an electrical solenoid.
0032The invention will now be described with reference to and/or as shown in the accompanying drawings of which, <ul id="ul0001" list-style="none" compact="compact"><li><figref idref="f0001">FIGURE 1</figref> is an illustration of an apparatus for testing a biological fluid according to the third aspect of the invention,</li><li><figref idref="f0002">FIGURE 2</figref> is an illustration of a section of the apparatus of <figref idref="f0001">Figure 1</figref> along line X in <figref idref="f0001">Figure 1</figref>, and</li><li><figref idref="f0003">FIGURE 3</figref> is an illustration of typical graphs of light output versus time produced using the method of the first and second aspects of the invention.</li></ul>
0033A sample of biological fluid is collected. In this case, the biological fluid is milk, and a 0.1 mL sample is preferably taken directly from the milk line and automatically introduced into the reaction chamber.
0034A liquid reagent including a light amplifier, in this case 5mM/L luminol, an iron rich pH buffer solution (1mM/L Fe and 25 mM/L Tris Buffer), and reagent grade water, is added to the sample. This is done in a temperature controlled chamber whose temperature is held above 35°C and preferably below 45°C.
0035An example of an apparatus used to collect the milk sample and introduce the reagent into the sample is illustrated in <figref idref="f0001">Figures 1</figref> and <figref idref="f0002">2</figref>.
0036Referring to the figures there is shown a cylindrical tube 10 made from an opaque and biologically inert material such as stainless steel, a lower end of which is located in a correspondingly dimensioned cylindrical recess 12a in a base 12 made from a transparent polymeric material, the base 12 substantially sealing the lower end of the tube 10.
0037A piston 14 is locates within the tube 10, and two O-rings 16 are mounted in grooves around the circumference of the piston 14 and provide a substantially fluid tight seal between the piston 14 and the tube 10 whilst still permitting movement of the piston 14 relative to the tube 10. A reaction chamber 18 is thus formed in the tube 10 between the piston 14 and the base 12.
0038A light detector 24 is mounted in the base 12. In this example, the light detector is a photo-diode, as this is a low cost component which has been found to be capable of detecting the light intensities typically emitted by the sample. The surface of the recess 12a in the base 12 is coated with an opaque material, other than a window portion adjacent to the light detector 24. Thus the reaction chamber 18 is generally light tight, other than a window allowing light to fall on the light detector 24.
0039The base 12 is provided with three ports 20a, 20b, 20c, each of which is provided with an electrical valve operable by means of a controller 21 a, 21b, 21c to open or close the port 20a, 20b, 20c.
0040The first port 20a is connected to a supply of biological fluid, in this case, to a milk conduit 26 in an automatic milking system via an auxiliary milk conduit 28, the auxiliary milk conduit 28 being typically connected to the main milk conduit 26 between a vacuum source used to draw milk from the cow and a milking cluster on the cow's udder, the second port 20b is connected to a supply of reagent 30, and the third port 20c is connected to a waste outlet 32.
0041Preferably the reaction chamber 18 is connected to a source of milk from a single cow only, so that the milk from each individual cow is tested. It would be possible, however, to connect the reaction chamber 18 to be connected to a source of milk from a plurality of cows mixed together, for example by drawing the milk sample from the central milk collection tank, but in this case, the test would merely identify that one or more cows in the herd is/are infected, and would not indicate which cow or cows were infected.
0042The piston 14 is connected to an actuator 34 such as a solenoid by means of a shaft 22, and the activation of the actuator 34 is controlled by a further controller 36.
0043A milk sample and reagent are drawn into the reaction chamber 18 by opening the valves in the first 20a and second 20b ports, and activating the actuator 34 to move the piston 14 upwards in the tube 10.
0044In order to prevent the milk sample itself from preventing light from reaching the light detector, the concentration of the reagent is selected such that the volume of the reagent used is approximately three times the volume of the milk sample. Thus, for a 0.1mL milk sample, 0.3mL of reagent is used. This has been found to reduce the opacity of the milk sample to a sufficient degree to allow as much light emitted by the sample as possible to reach the light detector.
0045In order to ensure that the correct proportion of sample and reagent are introduced into the reaction chamber 18, the valve on the first port 20a may be controlled to remain open for longer than the valve on the second port 20b. Alternatively, the valves may have mitering orifices such that the required proportions of fluid is delivered whilst both are open for the same length of time.
0046Once the required amount of sample and reagent have been introduced into the reaction chamber 18, the valves are activated to close the inlet ports 20a, 20b. The light detector is immediately activated and light measurement is continued typically for up to 3 minutes although for reasons explained below, results can be obtained within the first 10 seconds although if monitoring is maintained for an additional 60-180 seconds, the method may detect very low levels of infection. The light intensity over this time period is recorded and processed to produce a graph of light output against time using a data recording and processing device 38 such as a PC. The resulting graph is then compared with a comparable plot obtained using milk from a healthy animal to determine whether the animal has mastitis.
0047Information regarding the expected output for a sample from a healthy animal is preferably stored in the memory of the PC 38, and the PC 38 is preferably programmed to make the necessary comparison and to provide an output signal indicating whether the animal is healthy or infected. The output signal may be displayed on a visual display device such as a PC monitor, or in a more simple system, the presence of an infected animal may be indicated using a warning light, or by means of an audible indicator device such as a buzzer or alarm bell.
0048The PC 38 be connected to a plurality of testing apparatus, and may therefore collect and process data from the milk samples of a plurality of cows, in which case it would be necessary for a visual display device to provide means of identifying which cow is infected.
0049When the test is complete, the valve in the third port 20c is opened and the actuator 34 activated to move the piston 14 downwards in the tube 10 to expel the sample and reagent mixture into the waste outlet 32. The reaction chamber 18 may be cleaned once milking is completed by drawing cleaning fluid in from the main milk line 26 during cleaning of the entire milking system, and expelling the cleaning fluid through the outlet port 20c.
0050When an animal has clinical mastitis, and is therefore producing increased numbers of neutrophils in response to the infectious agent, then phagocytosis was already taking place before the sample is mixed with the reagent. When the reagent is mixed with the sample, the light amplifier reacts with the superoxides already produced during phagocytosis and produces light. Thus, light is detected as soon as the light measurements are started, and the light output therefore is at a peak immediately the milk sample and reagent containing light amplifying compound are mixed, when light measurements are started and light output decreases rapidly to reach a background level after several minutes of testing.
0051A typical plot of light output versus time for an animal with mastitis is shown in <figref idref="f0003">Figure 3a</figref>.
0052Thus, the presence of the initial peak in light output provides an indication that an animal has an infection such as mastitis.
0053Moreover, the area under the light output-peak provides an indication of the number of neutrophils in the sample. Thus, where the light output is recorded using a PC, the PC is preferably programmed to integrate the light output versus time curve, compare the results with standard data, and calculate and display the number of neutrophils in the sample.
0054The apparatus used to carry out the test is preferably calibrated and verified using positive controls such as luminol diluted in hydrogen peroxide, as this produces a light output similar to milk.
0055Experiments have shown that it is possible to detect neutrophil concentrations as low as 100,000 cells per mL using the method of the invention, and above the level of 300,000 cells per mL, the accuracy of the test is high and matches the accuracy of current best laboratory based tests.
0056preferably the test should be carried out as soon as possible after collection of the sample, as it has been found that the accuracy and reliability of the results decreases as the length of time between collecting the sample and carrying out the test increases. It is believed that this is as a result of superoxide concentrations decreasing with time.
0057Preferably the data processing apparatus 38, and the controllers 36, 21a, 21b, 21c for the actuator 34 and valves are combined in a single integrated control unit, which may be separate from or integrated with a control unit for controlling the vacuum source and the other apparatus used in the milking. process.
0058It is not necessary to use luminol as the light amplifier. Other suitable substances such as lucigenin, Vargula hilgendorfi luciferin derivatives, or a photoprotein may alternatively be used.
0059In the method of the invention, it is not necessary to include a phagocyte stimulator in the reagent. In order to reduce the time taken to complete a test, it is possible to base a diagnosis solely on the presence or absence of the initial light burst.
0060Although the method of the invention has been described with particular reference to an in-line milk testing method, the methods of the invention may be utilised in a non-in-line situation such as in a laboratory.
0061With suitable apparatus the invention may be utilised to provide quantitative test results rather than merely qualitative ranges of results.
3 sheets
Sheet 1 Sheet 2 Sheet 3
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO0129518A1 | Cites | World Intellectual Property Organization (WIPO) | Examiner |
| EP0489602A | Cites | European Patent Office (EPO) | – |
| WO0135728A | Cites | World Intellectual Property Organization (WIPO) | – |
| WO0129518A1 | Cites | World Intellectual Property Organization (WIPO) | – |
| GB2001434A | Cites | United Kingdom | – |
| GB2350421A | Cites | United Kingdom | – |
| US6297045B1 | Cites | United States of America | – |
12 members in 9 offices
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 0227296 | United Kingdom | A | |
| 0227296 | United Kingdom | – | |
| 0305029 | United Kingdom | W | |
| WO2003GB05029 | – | – | – |
| GB20020027296 | – | – | – |
| 0227296 | – | – | – |
| 2003005029 | – | – | – |
Members12
| Document | Office | Kind | |
|---|---|---|---|
| GB2395552A | United Kingdom | A | |
| CA2506259A1 | Canada | A1 | |
| WO2004048968A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003286246A1 | Australia | A1 | |
| EP1563292A1 | European Patent Office (EPO) | A1 | |
| PL375570A1 | Poland | A1 | |
| US2006124064A1 | United States of America | A1 | |
| NZ540020A | New Zealand | A | |
| ZA200504517B | South Africa | B | |
| AU2003286246B2 | Australia | B2 | |
| US7757635B2 | United States of America | B2 | |
| EP1563292B1This record | European Patent Office (EPO) | B1 |
60 legal events, as 9 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Discontinued in the netherlands as no translation has been filedVDEP | VDEP | NL | |
| Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05 | MK05 | AT | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Reference to at number (ep patent enters austrian national phase)REF | REF | AT | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Applications withdrawn, deemed to be withdrawn, or refused after publication in hong kongWithdrawnWD | WD | HK | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1563292
- Publication, DOCDB
- 1563292
- Publication, EPODOC
- EP1563292
- Application
- 3776989
- Application, DOCDB
- 03776989
- Application, EPODOC
- EP20030776989
Titles3
- German
- VERFAHREN UND VORRICHTUNG ZUM NACHWEIS VON MASTITIS
- English
- METHOD AND APPARATUS FOR DETECTING MASTITIS
- French
- METHODE ET APPAREIL PERMETTANT DE DETECTER UNE MAMMITE
Classification
- CPC, 5
- A01J5/0135
- A01J5/045
- G01N21/76
- G01N33/04
- G01N33/56911
- IPC, 6
- G01N33 04
- A01J5 013
- A01J5 04
- G01N21 76
- G01N33 487
- G01N33 569
Designated states27
- Contracting states, 27
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Romania
- Sweden
and 3 moreShow fewer
- Slovenia
- Slovakia
- Türkiye
